Frequent misdiagnosis of adult polyglucosan body disease

Journal of Neurology

Volumn 262, Issue 10, 2015, Pages 2346-2351

  Hellmann, Mark A ^a,b   Kakhlon, Or ^c   Landau, Ezekiel H ^c   Sadeh, Menachem ^d   Giladi, Nir ^b,e   Schlesinger, Ilana ^f   Kidron, Daphne ^g   Abramsky, Oded ^c   Reches, Avinoam ^c   Argov, Zohar ^c   Rabey, Jose M ^h   Chapman, Joab ^b,i   Rosenmann, Hanna ^c   Gal, Aya ^c   Moshe Gomori, J ^c   Meiner, Vardiella ^c   Lossos, Alexander ^c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^f RAMBAM MEDICAL CENTER   (Israel)

^g MACCABI HEALTHCARE SERVICES   (Israel)

^h ASSAF HAROFEH MEDICAL CENTER   (Israel)

ⁱ SHEBA MEDICAL CENTER   (Israel)

Author keywords

Adult polyglucosan body disease; GBE1 gene; Glycogen branching enzyme; Spastic paraparesis

Indexed keywords

1,4 ALPHA GLUCAN BRANCHING ENZYME; ANTITHROMBOCYTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ACHILLES REFLEX; ADULT; ADULT POLYGLUCOSAN BODY DISEASE; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BABINSKI REFLEX; BLADDER DYSFUNCTION; CEREBROVASCULAR DISEASE; CERVICAL SPINAL CORD; CLINICAL ARTICLE; DIAGNOSTIC ERROR; FEMALE; GAIT DISORDER; GBE1 GENE; GENE; HUMAN; LEUKOENCEPHALOPATHY; LOWER URINARY TRACT SYMPTOM; MALE; MULTIPLE SCLEROSIS; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROSTATECTOMY; SENSORIMOTOR NEUROPATHY; SENSORY DYSFUNCTION; SPASTICITY; DELAYED DIAGNOSIS; GLYCOGEN STORAGE DISEASE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDY;

ADULT; AGED; DELAYED DIAGNOSIS; DIAGNOSTIC ERRORS; FEMALE; GLYCOGEN STORAGE DISEASE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES;

EID: 84944511301     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7859-4     Document Type: Article

References (17)

1. Robitaille Y, Carpenter S, Karpati G, DiMauro SD (1980) A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora’s disease and normal ageing. Brain 103:315–336
2. Lossos A, Meiner Z, Barash V et al (1998) Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen branching enzyme gene. Ann Neurol 44:867–872
3. Mochel F, Schiffmann R, Steenweg ME et al (2012) Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings. Ann Neurol 72:433–441
4. Krim E, Vital A, Macia F, Yekhlef F, Tison F (2005) Atypical parkinsonism combining alpha-synuclein inclusions and polyglucosan body disease. Mov Disord 20:200–204
5. Boulan-Predseil P, Vital A, Brochet B, Darriet D, Henry P, Vital C (1995) Dementia of frontal lobe type due to adult polyglucosan body disease. J Neurol 242:512–516
6. McDonald TD, Faust PL, Bruno C, DiMauro S, Goldman JE (1993) Polyglucosan body disease simulating amyotrophic lateral sclerosis. Neurology 43:785–790
7. Billot S, Herve D, Akman HO et al (2013) Acute but transient deterioration revealing adult polyglucosan body disease. J Neurol Sci 324:179–182
8. Paradas C, Akman HO, Ionete C et al (2014) Branching enzyme deficient. Expanding the clinical spectrum. JAMA Neurol 71:41–47
9. Akman HO, Kakhlon O, Coku J et al (2014) Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease. JAMA Naurol 72:441–445
10. Hussain A, Armistead J, Gushulak L et al (2012) The adult polyglucosan body disease mutation GBE1 c.1076A>C occurs at high frequency in persons of Ashkenazi Jewish background. Biochem Biophys Res Commun 426:286–288
11. Lossos A, Klein CJ, McEvoy KM, Keegan BM (2009) A 63-year-old woman with urinary incontinence and progressive gait disorder. Neurology 72:1607–1613
12. Pantoni L (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9:689–701
13. Alter M, Kahana E, Zilber N, Miller A (2006) Multiple sclerosis frequency in Israel’s diverse populations. Neurology 66:1061–1066
14. Rice CM, Cottrell D, Wilkins A, Scolding NJ (2013) Primary progressive multiple sclerosis: progress and challenges. J Neurol Neurosurg Psychiatry 84:1100–1106
15. Kim H-J, Jeon BS, Jellinger KA (2015) Diagnosis and differential diagnosis of MSA: boundary issues. J Neurol. doi:10.1007/s00415-015-7654-2
16. Flanagan EP, Krecke KN, Marsh RW et al (2014) Specific pattern of gadolinium enhancement in spondylotic myelopathy. Ann Neurol 76:54–65
17. Lepor H (2004) Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol 6(S9):3–10